Publicaciones en colaboración con investigadores/as de Imperial College London (13)

2024

  1. Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysis

    The Lancet Psychiatry, Vol. 11, Núm. 1, pp. 36-46

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis—findings from the EU-GEI study

    Molecular Psychiatry, Vol. 28, Núm. 5, pp. 2095-2106

2022

  1. Genetic variants associated with longitudinal changes in brain structure across the lifespan

    Nature neuroscience, Vol. 25, Núm. 4, pp. 421-432

  2. Subtly altered topological asymmetry of brain structural covariance networks in autism spectrum disorder across 43 datasets from the ENIGMA consortium

    Molecular Psychiatry, Vol. 27, Núm. 4, pp. 2114-2125

2021

  1. Author Correction: Altered structural brain asymmetry in autism spectrum disorder in a study of 54 datasets (Nature Communications, (2019), 10, 1, (4958), 10.1038/s41467-019-13005-8)

    Nature Communications

  2. Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders

    JAMA Psychiatry, Vol. 78, Núm. 1, pp. 47-63

2019

  1. Altered structural brain asymmetry in autism spectrum disorder in a study of 54 datasets

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: an umbrella review of meta-analyses

    Acta Psychiatrica Scandinavica, Vol. 137, Núm. 2, pp. 88-97

2016

  1. BAP Position Statement: Off-label prescribing of psychotropic medication to children and adolescents

    Journal of Psychopharmacology, Vol. 30, Núm. 5, pp. 416-421

2014

  1. Schizophrenia-Time to commit to policy change

    Schizophrenia Bulletin, Vol. 40, Núm. SUPPL. 3

2013

  1. Cognition in schizophrenia: Summary nice consultation meeting 2012

    European Neuropsychopharmacology

  2. Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia

    Schizophrenia Research, Vol. 150, Núm. 2-3, pp. 328-333